To whom it may concern, Due to unprecedented increases in the costs of raw materials, logistics/freight, energy, and labor, Halocarbon Life Sciences, LLC will be increasing the price of its Trifluoro and Hexafluoro products effective April 1, 2022. This increase applies to the following products: • Trifluoro Acetic Acid (TFA) • Biograde TFA • Trifluoroethanol
January 7, 2022 Dechra is pleased to announce the acquisition of the veterinary approved Isoflurane®, USP Inhalant Anesthetic and Sevoflurane®, USP Inhalant Anesthetic from Halocarbon. Mike Eldred, President of Dechra North America, stated, “These products are utilized daily in veterinary hospitals and complement our current sedative and anesthetic product range. We are excited to continue
Dear Valued Customer, Due to significant increases in the cost of our raw materials, labor costs, and freight/logistics costs, Halocarbon Life Sciences, LLC will be increasing the price of its products by 8% effective December 1, 2021. If you have any questions about how this price increase will impact your business with Halocarbon, please contact